<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04711044</url>
  </required_header>
  <id_info>
    <org_study_id>N-20200005 (third sub-project)</org_study_id>
    <nct_id>NCT04711044</nct_id>
  </id_info>
  <brief_title>Investigation of a New Human Model for Itch</brief_title>
  <official_title>Characterization of New Human Models of Non-histaminergic Itch and Their Interaction With the TRPM8 Receptor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This third sub-project aims to evaluate the interaction between the TRPM8 receptor and&#xD;
      pruritus by studying the anti-pruritic effect of TPRM8-agonist L-menthol on histaminergic and&#xD;
      non-histaminergic itch induced using three different pruritogens: histamine, cowhage and&#xD;
      papain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">July 5, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measuring itch intensity by computerized Visual Analog Scale Scoring</measure>
    <time_frame>For 15 minutes</time_frame>
    <description>We will ask the subjects to rate the sensation of itch on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates &quot;no itch&quot; and 100 indicates &quot;worst itch imaginable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring pain intensity by computerized Visual Analog Scale Scoring</measure>
    <time_frame>For 15 minutes</time_frame>
    <description>We will ask the subjects to rate the sensation of pain on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates &quot;no pain&quot; and 100 indicates &quot;worst pain imaginable&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Superficial blood perfusion measurement</measure>
    <time_frame>After 15 minutes</time_frame>
    <description>Superficial blood perfusion is measured by a Speckle contrast imager</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring Alloknesis</measure>
    <time_frame>15 minutes</time_frame>
    <description>Alloknesis is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 milliNewton of force).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of Cold Detection Thresholds (CDT)</measure>
    <time_frame>15 minutes</time_frame>
    <description>The tests for thermal sensation will all be conducted using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Cold PainThresholds (CPT)</measure>
    <time_frame>15 minutes</time_frame>
    <description>The tests for thermal sensation will all be conducted using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Heat Pain Thresholds (HPT)</measure>
    <time_frame>15 minutes</time_frame>
    <description>The tests for thermal sensation will all be conducted using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Warm Detection Thresholds (WDT)</measure>
    <time_frame>15 minutes</time_frame>
    <description>The tests for thermal sensation will all be conducted using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Pain to Supra-threshold Heat Stimuli</measure>
    <time_frame>15 minutes</time_frame>
    <description>The tests for thermal sensation will all be conducted using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Mechanical Pain Thresholds (MPT)</measure>
    <time_frame>15 minutes</time_frame>
    <description>This test is conducted using a pin-prick set.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Mechanical Pain Sensitivity (MPS)</measure>
    <time_frame>15 minutes</time_frame>
    <description>This test is conducted using a pin-prick set.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Touch Pleasantness (TP)</measure>
    <time_frame>15 minutes</time_frame>
    <description>Pleasant touch sensation measured using a standardized sensory brush</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Itch</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Papain</intervention_name>
    <description>Papain will be applied using cowhage spicules inactivated by heat</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Histamine</intervention_name>
    <description>To deliver histamine, standard allergy skin prick test (SPT) lancets are applied</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cowhage</intervention_name>
    <description>Cowhage spicules are 1-2 mm in length and have a diameter of 1-3 μm. The spicules are inserted by gently rubbing 30-35 spicules into a 1 cm diameter skin area.</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>L-menthol</intervention_name>
    <description>A 1 mL aliquot is dispensed onto a 2,5 × 2,5 cm cotton pad and placed on a 6 × 6 cm sheet of medical tape.</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy men and women&#xD;
&#xD;
          -  18-60 years&#xD;
&#xD;
          -  Speak and understand English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Drug addiction defined as any use of cannabis, opioids or other addictive drugs&#xD;
&#xD;
          -  Previous or current history of neurological, dermatological, immunological&#xD;
             musculoskeletal, cardiac disorder or mental illnesses that may affect the results&#xD;
             (e.g. neuropathy, muscular pain in the upper extremities, etc.).&#xD;
&#xD;
          -  Lack of ability to cooperate&#xD;
&#xD;
          -  Current use of medications that may affect the trial such as antihistamines,&#xD;
             antipsychotics and pain killers, as well as systemic or topical steroids.&#xD;
&#xD;
          -  Skin diseases&#xD;
&#xD;
          -  Moles, scars or tattoos in the area to be treated or tested.&#xD;
&#xD;
          -  Hypersensitivity to papaya and mango fruit, cashew nuts, rubber latex&#xD;
&#xD;
          -  Consumption of alcohol or painkillers 24 hours before the study days and between these&#xD;
&#xD;
          -  Acute or chronic pain&#xD;
&#xD;
          -  Participation in other trials within 1 week of study entry (4 weeks in the case of&#xD;
             pharmaceutical trials)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aalborg University</name>
      <address>
        <city>Aalborg</city>
        <state>Nordjylland</state>
        <zip>9229</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 13, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg University</investigator_affiliation>
    <investigator_full_name>Silvia Lo Vecchio</investigator_full_name>
    <investigator_title>PhD, Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
    <mesh_term>Histamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

